Volume 10, Issue 8 e6200
CASE REPORT
Open Access

Simultaneous occurrence of subarachnoid hemorrhage and cerebral venous sinus thrombosis: A systematic review of cases

Damilola Jesuyajolu

Corresponding Author

Damilola Jesuyajolu

Department of Neurosurgery, Association of Future African Neurosurgeons, Yaounde, Cameroon

Correspondence

Damilola Jesuyajolu, Department of Neurosurgery, Association of Future African Neurosurgeons, Yaounde, Cameroon.

Email: [email protected]

Search for more papers by this author
Olatomiwa Olukoya

Olatomiwa Olukoya

Department of Neurosurgery, Surgery Interest Group of Africa, Lagos, Nigeria

Search for more papers by this author
Terngu Moti

Terngu Moti

Department of Neurosurgery, Surgery Interest Group of Africa, Lagos, Nigeria

Search for more papers by this author
First published: 03 August 2022

All authors contributed equally to the paper.

Abstract

Although the leading causes of subarachnoid hemorrhage (SAH) are aneurysm rupture and arteriovenous malformations, cerebral venous sinus thrombosis (CVST) can, in rare cases, be associated with SAH. This phenomenon is an uncommon presentation, with less than a hundred cases reported based on our review of the literature. The purpose of this review is to highlight what is known regarding these cases, how they are managed and to highlight the need for further studies that will serve as a basis for the development of a standard management guideline across board. The following databases were searched: PubMed and Ovid Embase. A complementary search of Google Scholar and AJOL was done. Gray literature search was also conducted on the Google search engine for any additional relevant papers. We were able to extract data regarding 33 cases from 29 identified studies. The mean age was 46.6 ± 14.08. 17 (51.5%) of the cases were female, and the female-to-male ratio is 1.1:1. Headache was by far the commonest symptom, occurring in 82% of cases followed by seizures in 42% of cases. Four patients (12%) had loss of consciousness while 5 patients (15%) had some form of focal neurologic deficit. Twenty patients had cerebral venous sinus thrombosis in at least two different sinuses. The superior sagittal sinus was the most common location for CVSTs (79%), followed by the transverse sinus (57.5%). Twenty-nine cases (89%) were managed with anticoagulation alone and one case had a mechanical thrombectomy. We have performed a comprehensive review of cases that had the simultaneous occurrence of SAH and CVST and have identified their peculiarities and the challenges to management. Further research is needed in order to identify a causal relationship and to serve as a basis for the development of a standard management guideline across the board.

1 INTRODUCTION

Although the leading causes of subarachnoid hemorrhage (SAH) are aneurysm rupture and arteriovenous malformations, cerebral venous sinus thrombosis (CVST) can, in rare cases, be associated with SAH.1 This phenomenon is an uncommon presentation, with less than a hundred cases reported based on our review of the literature. CVST itself typically presents with headache, nausea, vomiting, weakness, loss of vision, and seizure.2 Because of its rarity, a high index of suspicion is important in making the diagnosis.3

CVST accounts for 1% of all strokes4, 5 and has a mortality as high as 30% with the annual incidence ranging from 0.22 to 1.57 per 100,000. It is more common in women than men.6, 7 Multiple reversible and irreversible factors are associated with CVST and include surgery, thrombophilia, antiphospholipid syndrome, cancer, inflammatory bowel disease, use of the oral contraceptive pill, infection, and pregnancy.8

The reason why SAH might occur together with CVST is still debated. In some cases, they could be coincidental. However, there are many hypotheses with regards a causal relationship between the two entities; hence, there is a need to review all the cases in the existing literature to see the similarities and differences across these rare cases and presentations. The purpose of this review is to highlight what is known regarding these cases, how they are managed and to highlight the need for further studies that will serve as a basis for the development of a standard management guideline across board. In this article, we systematically reviewed all such published cases of CVST and SAH occurring concurrently, noting their common characteristics, imaging findings, treatment, and outcomes.

2 METHOD AND MATERIALS

2.1 Source of information and search

We followed the PRISMA guidelines for conducting systematic reviews. To identify potentially relevant papers, the following databases were searched: PubMed and Ovid Embase. A complementary search of Google Scholar and African Journal Online (AJOL) was done. Gray literature search was also conducted on the Google search engine for any additional relevant papers. The results were exported into an excel document and duplicates were removed. The search strategy is presented in Table A1 in Appendix 1.

2.2 Selection criteria

We identified cases where SAH and CVST occurred together. We included case reports and case series, which included the aforementioned. We excluded posters, abstract-only papers, reviews, meta-analyses, commentaries, and letters to the editor. We excluded articles that were not written in the English language.

2.3 Selection of sources of evidence

Three reviewers working independently evaluated the titles, abstracts, and then full text of all cases identified by our searches for relevant papers. We resolved disagreements on study selection and data extraction by consensus where necessary. The process is summarized in Figure 1.

Details are in the caption following the image
Prisma flow chart

2.4 Data extraction

A data-charting form was jointly developed by the three authors to determine which data to extract. The reviewers then read each article extensively and populated the data extraction form with relevant details. The authors continually discussed the results and continuously updated the data-charting form in an iterative process. We extracted data on the characteristics of each patient/case (Age, gender, symptoms at presentation and their duration), diagnostic modalities for the subarachnoid hemorrhage and CVST, the location of the SAH and CVSTs, possible etiology (presence of aneurysms, trauma, coagulation disorders), the treatment modalities and the outcomes. We were able to extract data regarding 33 cases from 29 identified studies. A summary of the case studies is seen in Table A2 in Appendix 1.

2.5 Investigated patient characteristics

The mean age was 46.6 ± 14.08. 17 (51.5%) of the cases were female, and the female-to-male ratio was 1.1:1. One case had hyperhomocysteinemia while another had C667T mutations (Heterozygous for methylenetetrahydrofolate reductase). Only one case had a recent use of antiplatelets (Clopidogrel) prior to the diagnosis of CSVT and SAH.

2.6 Clinical symptoms and Imaging

Headache was by far the commonest symptom, occurring in 82% of cases followed by seizures in 42% of cases. Four patients (12%) had loss of consciousness while 5 patients (15%) had some form of focal neurologic deficit. Other symptoms included dizziness, nausea, vomiting, gait disturbance and ataxia. The diagnostic modalities used included a non-contrast computed tomography (CT) scan, computed tomography angiography (CTA), computed tomography venography (CTV), magnetic resonance imaging (MRI), magnetic resonance venography (MRV), and digital subtraction angiography (DSA). Twenty-five (75.7%) of the studies had an MRI done, while only 17 (51.5%) of them had a further MRV done to confirm the venous thrombosis. Twenty-seven of the cases had a non-contrast CT scan done which showed evidence of subarachnoid hemorrhage. Four patients later had a CTA, while another three had a magnetic resonance angiography (MRA) done to exclude an aneurysmal cause. Only one patient had a CTV done.

2.7 Diagnosis, treatment, and outcomes

Twenty patients (60.6%) had cerebral venous sinus thrombosis in at least two different sinuses. Of the different locations for the CVSTs, the superior sagittal sinus was the most common location (79%), followed by the transverse sinus (57.5%). Only one case of CVST and SAH had an accompanying intracerebral hemorrhage (ICH). The locations of the subarachnoid hemorrhage were more diverse, ranging from the perimesencephalic areas and cerebral convexities to the Sylvian fissures and interhemispheric fissures. Twenty-five of them involved the cerebral convexities while 7 of them involved the subarachnoid cisterns. Most of the subarachnoid hemorrhages were non-aneurysmal. Only one patient had an aneurysmal rupture; the location of the aneurysm was in the anterior communicating artery. Twenty-nine cases (89%) were managed with anticoagulation alone and one case had a mechanical thrombectomy first prior to anticoagulation. One case was managed with dehydration, scavenging free radicals, and nerve protective therapy, while another was managed with hydration and osmotic diuresis (with an eventual decompressive craniectomy for persistent raised ICP). The only case of the aneurysm was managed with coil embolization. All 28 cases that discussed the status at discharge and a few weeks after reported different ranges of improvement; recovery ranged from improvement in symptoms and partial recanalization to full recovery and full recanalization of the vessels.

3 DISCUSSION

Subarachnoid hemorrhage should be considered in the event of a sudden worsening headache.9 The diagnostic modality of choice for subarachnoid hemorrhage in the initial stages is a non-contrast CT scan.9, 10 With an equivocal result, a lumbar puncture is advised; however, given the increased sensitivity of a non-contrast CT scan within the six-hour timeframe, the choice to undertake a lumbar puncture should be through a shared decision-making process.9 As aneurysms are a common cause of SAH, CTA scans are important in demonstrating a causative aneurysm.9 A non-contrast CT scan is also a useful diagnostic modality for diagnosing a CVST as it can show findings that include, but are not limited to, venous sinus or deep vein hyper-density.11, 12 CT venography and/or MR venography are recommended diagnostic modalities of choice, as recommended by the European Stroke Organization.13

Transverse sinuses, superior sagittal sinuses, and the sigmoid sinus are the most common sites of CVSTs, and in most cases, multiple sinuses are affected.14-16 This is consistent with the findings of our review study, which showed that multiple sinuses were frequently affected with the superior sagittal sinus and the transverse sinus being the commonest sites. In cases with a coexisting cerebral venous sinus thrombosis, the perimesencephalic region is a common location for non-aneurysmal SAH.17, 18 The most common locations for aneurysms are in the circle of Willis, particularly the anterior communicating artery and the internal carotid artery.19, 20

A third of CVST cases might present with intracerebral hemorrhage.21 However, there is a paucity of literature on how common it is for CVST to occur with subarachnoid hemorrhage. One hypothesis of ‌why SAH may occur simultaneously with CVST is that the blood from the ensuing hemorrhagic infarct (resulting from the venous thrombosis) may extend into the subarachnoid space.22 This may certainly be the case in some of our findings where there was parenchymal hemorrhage besides the presence of CVST and SAH; however, its absence (also seen in many of the cases identified) may suggest a more direct causal relationship. A leading hypothesis supporting this stipulates that when CVST occurs, the ensuing secondary venous hypertension could be transmitted to the cortical veins, leading to the dilation and rupture of the fragile thin-walled cortical veins in the subarachnoid space.17, 23 Sometimes, the occurrence of both entities together could be coincidental, as seen in instances with an aneurysmal cause of the SAH, like in some of the identified cases.

Regardless of etiology, the treatment of a patient with SAH and CVST occurring concurrently can pose a dilemma. The risk of rebleeding in SAH is high, and in the absence of immediate surgical intervention for aneurysmal SAH, antifibrinolytics have been advised.24 This is in sharp contrast to the standard treatment of CVSTs, which involves rapid anticoagulation and the stoppage of any prothrombotic medications.11 Using systemic anticoagulation where simultaneous subarachnoid hemorrhage exists might worsen the hemorrhage. In cases of simultaneous CVST and ICH, endovascular interventional therapy has been ‌ beneficial.25 There is a possibility that such interventions may also yield positive results when used in cases of CVST occurring with SAH. Interestingly, in our study, despite the SAH, most of the patients were treated with anticoagulant therapy with good outcomes reported. Despite our comprehensive review, this study was not without limitations. Because we excluded articles that were not in the English Language, we could have potentially missed relevant literature. There was also heterogeneity in the way the case reports were reported which meant some relevant data could have been missed. Regardless, this review will contribute to the growing body of work on this occurrence.

4 CONCLUSION

We have performed a comprehensive review of cases that had the simultaneous occurrence of SAH and CVST and have identified their peculiarities and the challenges to management. Further research is needed in order to identify a causal relationship and to serve as a basis for the development of a standard management guideline across the board.

AUTHOR CONTRIBUTIONS

D.J involved in conceptualization, methodology, software, validation, formal analysis, investigation, resources, data collection, data curation, writing—original draft, writing—review and editing, project administration, supervision, submission, and correspondence. O.O and T.M involved in conceptualization, methodology, software, validation, formal analysis, investigation, resources, data collection, data curation, writing—original draft, writing—review and editing.

ACKNOWLEDGMENTS

None.

    CONFLICT OF INTEREST

    The authors hereby declare that there are no competing interests.

    CONSENT

    As this was a review of cases in already literature, no individual consent was required. Consent was however obtained by the individual case reports used in this review in accordance with the journal's patient consent policy.

    APPENDIX 1

    TABLE A1. Search strategy
    MeSH/Keywords Database Time span Hits
    (“subarachnoid haemorrhage”[All Fields] OR “subarachnoid hemorrhage”[MeSH Terms] OR (“subarachnoid”[All Fields] AND “hemorrhage”[All Fields]) OR “subarachnoid hemorrhage”[All Fields]) AND ((“cerebrally”[All Fields] OR “cerebrum”[MeSH Terms] OR “cerebrum”[All Fields] OR “cerebral”[All Fields] OR “brain”[MeSH Terms] OR “brain”[All Fields]) AND (“venous thrombosis”[MeSH Terms] OR (“venous”[All Fields] AND “thrombosis”[All Fields]) OR “venous thrombosis”[All Fields])) PubMed Inception - April 07 381
    cerebral venous sinus thrombosis.mp. or cerebral sinus thrombosis/ AND subarachnoid hemorrhage.mp. or subarachnoid hemorrhage/ OVID Embase 1974 to 2022 April 07 665
    TABLE A2. The summary of studies
    Case Author (Year) Age/Sex Symptoms (duration) Imaging Location of Subarachnoid hemorrhage Location of CVST Anticoagulant use/Hypercoagulability Treatment Outcome
    1 Gajurel BP et al (2021) 58F Holocephalic headache with seizure on presentation (3 days) CTH, MRV, CTA Insular, perimesencephalic, ambient and suprasellar cisterns, Left Transverse Sinus None/NT LMWH, Levetiracetam and 3% Hypertonic Saline Home on dabigatran 150 mg twice daily; stable on follow-up
    2 Syed K et al (2021) 48 M Seizure and Altered Mental State (ND) CTH, MRI, DSA Bifrontal Superior Sagittal Sinus None/ND IV esmolol 50 mcg/kg/min infusion and nimodipine 60 mg Q4 hourly; levetiracetam 500 mg, then intravenous heparin and later transitioned to coumadin after CVT dx Treated and discharged with no neurological sequelae
    3 Kumar H et al (2021) 25F SOH, Confusion, LOC (2 days) MRI, MRV ND (review image) Right Transverse Sinus None/−ve Half dosage LMWH (60 mg subcutaneously once a day); Then full dose; Then warfarin Thrombosis resolved within 6 weeks
    4 Sun J et al (2018) 57F Dizziness; N&V (ND) CTH, MRA, MRV Partial gutter of the right frontal, parietal, and occipital lobes Superior and Inferior sagittal sinus None/−ve Dehydration, scavenging free radicals, and nerve protection therapy 18-month follow-up: no recurrent thrombosis, improvement of non-fluent aphasia, right limb muscle strength was slightly worse than normal.
    5 Amer RR et al (2018) 44F SOH (ND) CTA, MRA, MRv Prepontine cistern Left Transverse and sigmoid sinus None/−ve

    LMWH

    (Nadroparin, 6150AXaIU, subcutaneous injection, twice daily) in combination with intravenous warfarin 3 mg/day

    ND
    6 Abbas A et al (2018) 58 M LOC secondary to diarrhea and vomiting (ND) CTH, CTV Left temporal and parietal lobes Superior sagittal sinus and straight sinus None/−ve LMWH and Rivaroxoban ND
    7 Liu Y et al (2017) 35F LOC and Seizures (5 days) CTH, CTA, DSA Right temporal lobe Superior sagittal sinus and bilateral transverse sinus None/ND Mechanical thrombectomy; Catheter with Urokinase infiltration; LMWH, then anticoagulant ND
    8 Fu FW et al (2017) 45 M Occipital headaches, N&V (6 hours) CTH, CTA, DSA, MRI Perimesencephalic and prepontine cisterns Right Transverse Sinus None/−ve LMWH (Nadroparin, 6150AXaIU, subcutaneous injection, twice daily), warfarin 14 days later Improvement of symptoms 10 days post-treatment, complete absorption of hemorrhage at day 16, no neurologic deficit at 3 weeks
    9 Uniyal R et al (2017) 38 M Holocranial headache; Vomiting; R arm weakness (ND) CTH, MRI, MRA, MRV Left central sulcus Superior sagittal sinus None/ND LMWH followed by oral anticoagulation Recovered completely in 7–10 days
    10 Unal Ay et al (2016) 78 M Sudden-onset thunderclap headache, Stroke (ND) CTH, CTH Contrast, MRV Suprasellar cistern Transverse sinus, Bilateral Sigmoid Sinus, Superior Sagittal Sinus Clopidogrel/−ve Heparin infusion Symptom relief in two weeks
    11 Neubauer C et al (2016) 63F Headache (3 weeks) CT, MRI, CTA Left MCA/ACA territories Superior sagittal and right lateral dural sinus None/−ve Heparin followed by oral anticoagulation; Coil embolization, and smasmolytic Six months follow-up revealed complete aneurysm occlusion and progressive recanalization of CVT
    12 Anderson B et al (2015) 42 M Uncontrolled Jerking; Dysesthesia; LOC (ND) CT, CTA, MRI, MRV Right frontotemporal convexities Superior sagittal sinus, right transverse, and sigmoid sinus None/−ve Heparin then coumadin therapy MRI at 2 weeks - SAH resolved; MRI 4 months - partial recanalization of the dural sinuses
    13 Hassan Aet al (2015) 46 M Headache; Right-sided Weakness; Focal seizures (3 days) CTH, MRV, CTA Paramedian sulci (Bilateral) Superior sagittal sinus, transverse sinus and sigmoid sinus None/−ve Subcutaneous anticoagulation then Oral anticoagulation for 6 months Headache resolved over 1 week; Neurological symptoms over 4 weeks; Seizure free; Maintained on anti-epileptic drugs
    14 Hassan A et al (2015) 35 M Headache; Seizure (2 days) CTH, MRI, MRV Bilateral, predominantly over the left frontoparietal sulci Superior Sagittal Sinus None/−ve Dose-adjusted intravenous anticoagulation and then Oral anticoagulation Symptoms improved; Lost to follow-up at 4 months
    15 Arévalo-Lorido et al (2015) 70 M Progressive Occipital Headache and nausea (ND) CTH, MRI, MRA Right Parietal region Right Transverse Sinus None/Heterozygote for methylenetetrahydrofolate reductase C667T mutations; rest negative 60 mg LMH to 120 mg and then oral Anticoagulation ND
    16 Sahin N et al (2014) 48F Headache; gait disturbance (7 days) MRI, MRV sulci of the bilateral frontoparietal convexity Superior sagittal sinus None/ND Anticoagulation Improved
    17 Yamamoto et al (2013) 32F Head dullness; 9 days later headache and then seizure (ND) CTH, MRI Basal cisterns, bilateral sylvian fissures, and anterior interhemispheric fissure Superior sagittal sinus, straight sinus, right transverse sinus None/−ve Hydration Discharged with only a slight visual field defect in the right eye and returned to her previous occupation
    18 Sayadnasiri M et al (2012) 42F Headache, Vomiting, FND, Seizures (3 days) CTH, MRI, MRV Right parietal area Cerebral Dural Sinuses None/−ve Anticoagulation ND
    19 Sayadnasiri M et al (2012) 36 M Headache, FND, Seizures (3 weeks) CTH, MRI, MRV Right Sylvian fissure Right lateral and sigmoid sinuses and also superior sagittal sinus ND/−ve Anticoagulation Discharged with partial recovery 2 weeks later.
    20 Kato et al (2010) 52F Progressive occipital headache, nausea, and vomiting; generalized seizures 4 days into admission (ND) Cerebral Angiography, CTH Right temporal sulcus and bilateral cerebellar sulci Superior sagittal sinus, straight sinus, transverse sinus, and right sigmoid sinus None/−ve IV heparin and then Warfarin Near-complete neurological recovery within a month.
    21 Sharma et al (2010) 59 M Rapidly progressive and pulsatile headache then generalized seizures (ND) MRI, MRV right parasagittal high frontoparietal areas Superior sagittal sinus and bilateral transverse sinus None/−ve Subcutaneous LMWH and then oral warfarin Clinically satisfactory within six weeks
    22 Lai NK et al (2008) 34 M Headache, Seizure (3 days) CTH, DSA Right frontoparietal sulci Superior sagittal sinus None/−ve Intravenous heparin, then warfarin, and anticonvulsants MRI at 3 months demonstrated partial recanalization of the superior sagittal sinus.
    23 Jaiser et al (2008) 53F Spontaneous, sudden-onset occipital headache + mild neck stiffness (3 days) CTH, CTA, MRV Left frontal Superior sagittal sinus None/−ve IV unfractionated heparin, then warfarin under LMWH cover Recanalization of superior sagittal sinus after 6 months
    24 Ko YP et al (2007) 25F Headache, FND (3 days) CTH, MRI, MRV Left frontal Superior sagittal sinus None/−ve LMWH, then warfarin Symptoms improved within a few days
    25 Lin et al (2006) 44 M 1 episode of focal motor seizure of left arm; Thunderclap headache (ND) CTH, CTA, MRI Right parietal sulci Superior sagittal sinus, transverse sinus None/−ve IV heparin and then Warfarin L arm weakness resolved
    26 Rice H et al (2006) 56F Headache, neck stiffness, photophobia (ND) MRI, MRV Several cortical sulci along the right frontoparietal convexity SSS, left transverse sinus, Dural sinus None/ND Anticoagulation Clinical improvement within 1 week; Radiological improvement at 3 months
    27 Shukla et al (2006) 40 M Sudden headache associated with recurrent vomiting, photophobia and phonophobia + right focal seizures followed by R hemiparesis (ND) CTH, DSA, MRV Left sylvian fissure Superior sagittal, transverse sinuses, inferior sagittal sinus None/−ve LMWH, then warfarin Symptom-free at discharge
    28 Adaletli I et al (2005) 14 M Headache, nausea, vomiting, diplopia, and gait disturbance (ND) CTH, DSA Basal cisterns, bilateral sylvian fissures, anterior hemispheric fissure SSS, galenic vein, straight sinus None/ND Anticoagulation Symptoms and signs completely resolved
    29 Oppenheim et al (2005) 69 M Sudden-onset headache (ND) MRI + DSA subarachnoid spaces of the right frontal convexity Transverse and sagittal sinuses Previous history of DVT IV Heparin Complete radiologic and clinical recovery at follow-up
    30 Oppenheim et al (2005) 55F Headache, neck stiffness, nausea, seizure (ND) CTH, MRI, DSA bihemispheric; predominantly in the left insular sulci sagittal and the left transverse sinus None/−ve LMWH rapid clinical improvement and partial recanalization of the thrombosed sinus
    31 Oppenheim et al (2005) 32F partial seizure that was secondarily generalized. Headaches with a sudden-onset with vomiting (3 weeks) CTH, MRI, DSA diffuse SAH predominating in the anterior interhemispheric sulci sagittal and right transverse venous sinuses hyperhomocystinemia IV Heparin complete regression of her neurologic signs and headaches
    32 Oppenheim et al (2005) 51F severe headaches associated with focal neurologic symptoms (5 weeks) CTH, MRI diffuse bilateral acute SAH, sparing the basal cisterns Superior sagittal sinus prophylactic anticoagulant (not specified) for 2 months post ankle surgery Anticoagulation Rapid clinical and radiologic improvement
    33 Sztajzel et al (2001) 58F Severe headache of sudden-onset (1 day) CTH, CTA, MRI, MRA Right cerebellar region Right lateral sinus; right transverse/sigmoid sinus Previous history of DVT ND Resolution of symptoms after 4 weeks

    DATA AVAILABILITY STATEMENT

    The data that support the findings of this study are available from the corresponding author upon reasonable request.

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.